World's Best Scientists 2026 revealed!
Pascal Vranckx

Pascal Vranckx

D-Index & Metrics

Medicine

D-Index
85
Citations
90111
World Ranking
14326
National Ranking
179

Pascal Vranckx publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pascal Vranckx sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 354 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pascal Vranckx D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pascal Vranckx sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pascal Vranckx is affiliated with Hasselt University in Belgium and specializes primarily in the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine. Their academic work spans several related subfields, including Surgery, Biomedical Engineering, Internal Medicine, and Emergency Medicine.

Vranckx's research addresses various topics within cardiovascular health, particularly concentrating on antiplatelet therapy, atrial fibrillation management, coronary interventions, acute myocardial infarction, mechanical circulatory support devices, venous thromboembolism, and cardiac arrhythmias.

  • Antiplatelet Therapy and Cardiovascular Diseases
  • Atrial Fibrillation Management and Outcomes
  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Mechanical Circulatory Support Devices
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Arrhythmias and Treatments

The scientist's frequent collaborators include Marco Valgimigli, Stephan Windecker, Peter Jüni, Philippe Gabríel Steg, and Dik Heg.

  • Marco Valgimigli
  • Stephan Windecker
  • Peter Jüni
  • Philippe Gabríel Steg
  • Dik Heg

Vranckx's research is published extensively in several cardiovascular and medical journals. Notable publication venues where Vranckx has contributed multiple works include European Heart Journal Acute Cardiovascular Care, Journal of the American College of Cardiology, European Heart Journal, JACC: Cardiovascular Interventions, and Circulation.

  • European Heart Journal Acute Cardiovascular Care
  • Journal of the American College of Cardiology
  • European Heart Journal
  • JACC: Cardiovascular Interventions
  • Circulation

Recent significant papers featuring Vranckx's research contributions are:

  • 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (2020), European Heart Journal
  • 2023 ESC Guidelines for the management of acute coronary syndromes (2023), European Heart Journal
  • Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk (2021), New England Journal of Medicine
  • 2023 ESC Guidelines for the management of acute coronary syndromes (2023), European Heart Journal Acute Cardiovascular Care
  • P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials (2021), BMJ

Best Publications

  • Third universal definition of myocardial infarction

    Kristian Thygesen;Joseph S. Alpert;Allan S. Jaffe;Maarten L. Simoons

  • 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

    Borja Ibanez;Stefan James;Stefan Agewall;Manuel J Antunes

  • Clinical End Points in Coronary Stent Trials A Case for Standardized Definitions

    Donald E. Cutlip;Stephan Windecker;Roxana Mehran;Ashley Boam

  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

    A. Pieter Kappetein;Stuart J. Head;Philippe Généreux;Nicolo Piazza

  • Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium

    Roxana Mehran;Sunil V. Rao;Deepak L. Bhatt;C. Michael Gibson

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

    Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet

  • Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation

    A. Pieter Kappetein;Stuart J. Head;Philippe Généreux;Nicolo Piazza

  • Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials : A Consensus Report From the Valve Academic Research Consortium

    Martin B Leon;Nicolo Piazza;Eugenia Nikolsky;Eugene H. Blackstone

  • Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial

    Marco Valgimigli;Andrea Gagnor;Paolo Calabró;Enrico Frigoli

  • 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

    Borja Ibanez;Stefan James;Stefan Agewall;Manuel J. Antunes

  • Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials

    Martin B. Leon;Nicolo Piazza;Eugenia Nikolsky;Eugene H. Blackstone

  • Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting A Randomized Multicenter Trial

    Marco Valgimigli;Gianluca Campo;Monia Monti;Pascal Vranckx

  • Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

    Hector M. Garcia-Garcia;Eugène P. McFadden;Andrew Farb;Roxana Mehran

  • Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

    Pascal Vranckx;Marco Valgimigli;Lars Eckardt;Jan Tijssen

  • Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium.

    Gregg W. Stone;David H. Adams;William T. Abraham;Arie Pieter Kappetein

  • A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

    George D. Dangas;Jan G.P. Tijssen;Jochen Wöhrle;Lars Søndergaard

  • Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes

    Marco Valgimigli;Enrico Frigoli;Sergio Leonardi;Martina Rothenbühler

  • Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

    Marco Valgimigli;Enrico Frigoli;Dik Heg;Jan Tijssen

  • Standardized End Point Definitions for Coronary Intervention Trials

    Hector M. Garcia-Garcia;Eugene P. McFadden;Andrew Farb;Roxana Mehran

Frequent Co-Authors

Marco Valgimigli
Marco Valgimigli University of Bern
Patrick W. Serruys
Patrick W. Serruys University of Galway
Stephan Windecker
Stephan Windecker University of Bern
Peter Jüni
Peter Jüni University of Oxford
Christian W. Hamm
Christian W. Hamm University of Giessen
Philippe Gabriel Steg
Philippe Gabriel Steg Université Paris Cité
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Donald E. Cutlip
Donald E. Cutlip Beth Israel Deaconess Medical Center
Eugene P. McFadden
Eugene P. McFadden Cork University Hospital
Yoshinobu Onuma
Yoshinobu Onuma University of Galway

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but not ready to commit to a full medical degree, a range of related online programs provide alternative pathways into the field. One popular option is healthcare administration. Finding out which online healthcare administration programs have cahme accreditation? ensures your degree meets industry standards and increases job prospects.

Aspiring nurses may consider advancing from RN to BSN. Accessible options like online rn to bsn programs without clinical requirements make it easier for busy professionals to obtain higher qualifications while continuing to work.

For those aiming for advanced practice, accelerated routes are now available. Explore accelerated dnp programs or look into the shortest dnp program options to complete your doctorate in nursing practice faster and transition quickly into leadership roles.

These online degrees are designed for flexibility and career advancement. They represent exciting alternatives for students considering a future in healthcare beyond traditional medical school.

Best Scientists Citing Pascal Vranckx

Trending Scientists

Recently Published Articles